On Monday, Zenas Biopharma Inc (NASDAQ: ZBIO) was 17.10% jump from the session before settling in for the closing price of $36.15. A 52-week range for ZBIO has been $5.83 – $41.50.
When this article was written, the company’s average yearly earnings per share was at 65.34%. With a float of $21.93 million, this company’s outstanding shares have now reached $42.21 million.
Zenas Biopharma Inc (ZBIO) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Zenas Biopharma Inc stocks. The insider ownership of Zenas Biopharma Inc is 59.14%, while institutional ownership is 31.11%. The most recent insider transaction that took place on Oct 09 ’25, was worth 1,200,002. In this transaction Director of this company bought 63,158 shares at a rate of $19.00, taking the stock ownership to the 1,173,395 shares. Before that another transaction happened on Oct 09 ’25, when Company’s 10% Owner bought 126,315 for $19.00, making the entire transaction worth $2,399,985. This insider now owns 1,917,895 shares in total.
Zenas Biopharma Inc (ZBIO) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 65.34% per share during the next fiscal year.
Zenas Biopharma Inc (NASDAQ: ZBIO) Trading Performance Indicators
You can see what Zenas Biopharma Inc (ZBIO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 151.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.53, a number that is poised to hit -1.00 in the next quarter and is forecasted to reach -3.83 in one year’s time.
Technical Analysis of Zenas Biopharma Inc (ZBIO)
Analysing the last 5-days average volume posted by the [Zenas Biopharma Inc, ZBIO], we can find that recorded value of 0.61 million was better than the volume posted last year of 0.26 million. As of the previous 9 days, the stock’s Stochastic %D was 59.55%.
During the past 100 days, Zenas Biopharma Inc’s (ZBIO) raw stochastic average was set at 97.72%, which indicates a significant increase from 94.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.70 in the past 14 days, which was higher than the 2.43 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.51, while its 200-day Moving Average is $18.21. Now, the first resistance to watch is $44.83. This is followed by the second major resistance level at $47.32. The third major resistance level sits at $51.66. If the price goes on to break the first support level at $38.00, it is likely to go to the next support level at $33.66. Now, if the price goes above the second support level, the third support stands at $31.17.
Zenas Biopharma Inc (NASDAQ: ZBIO) Key Stats
There are 53,679K outstanding shares of the company, which has a market capitalization of 2.27 billion. As of now, sales total 5,000 K while income totals -156,990 K. Its latest quarter income was 0 K while its last quarter net income were -52,220 K.
